FDA draft guidances seek to maintain accurate drug information for patients in new media.

Is there potential for growth in Brazil's phytotherapic drug market?

Genentech's $1.7 billion acquisition of Seargon Pharmaceutical includes portfolio of investigational next-generation oral selective estrogen receptor degraders.

Regulators and industry leaders take on the task of securing the drug supply chain.

The oncology center and its manager were charged with obtaining and selling unapproved, potentially counterfeit, cancer-treatment drugs.

FDA releases guidance documents and rules on requirements for compounding human drug products.

Sandoz will supply antibiotic to developing countries as part of the United Nations' Every Newborn Action Plan.

Merck funds Bionomics with $20 million to progress therapies for cognitive impairment caused by central nervous system disorders

The collaboration will use Mersana Therapeutics Fleximer technology for antibody-drug conjugates.

Bristol-Myers Squibb issues a voluntary US recall of Coumadin (warfarin sodium) for injection due to presence of particulate matter.

Biotage has launched a purification technology, Accelerated Chromatographic Isolation (ACI), which converts simple flash purification into a faster and more economical way to isolate pure compounds.

This work marks the first joint project between regulators and HTA bodies on a European level and is part of their ongoing dialogue to support policymaker decisions in the future.

Onyx Scientific has announced plans to invest in continuous flow manufacturing to allow its customers to explore alternatives during product research and development programs.

PolySciTech's new launch, SpinSwiper, has the potential to speed up microparticle production.

GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world&s poorest children.

New toxicology study demonstrates decreased mortality and better tolerability of ADC generated with Smartag platform versus conventional technology.

Covance MarketPlace is designed to enable partnerships between the company';s emerging biotechnology and established pharmaceutical clients.

Cytovance Biologics completes GMP manufacture of ARMO BioSciences& lead product.

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China&s Food and Drug Administration's shortened serialization deadline.

Frontage Labs will expand its CMC facility in Exton, PA.

GSK Biologicals receives warning about cGMP compliance issues at its Quebec facility.

Novartis' 13th Annual Malaria Expert Panel focused on access to quality anti-malarials across Africa.

Rentschler plans to build two stainless-steel bioreactors to target market supply.

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

Recipharm and CTC will offer packages for Phase I studies.

SGS introduces the Cobas 6000 Analyzer System for its France-based laboratory.

Jones Packaging introduces a new solid dose vial line in its Toronto facility.

According to the National Bioscience Report, the US bioscience industry is on course for continued growth.